medical tourism

As borders reopen, private healthcare providers are experiencing a boost to their businesses & supporting growth to other sectors

Ong, Jaiswal, and DBS’ Tan have posted “buy” calls on Raffles Medical at target prices of $1.50, $1.55 and $1.63 respectively.

RHB is downgrading their call on TalkMed to “hold” from “buy” previously.

However, she warns that with the economy in a recession, patients’ willingness to spend on non-essential procedures may be affected.

SINGAPORE (June 12): Given the hit to medical tourism due to measures to curb the spread of Covid-19, hospital operators are likely to be more severely impacted in 2Q, according to CGS-CIMB Research.

TalkMed talks the talk, but can it walk the walk?

SINGAPORE (June 4): Integrated healthcare company Clearbridge Health says it is planning to open a new 1,500 sq ft clinic along Causeway Bay, Hong Kong, to serve more domestic patients and medical tourists.

SINGAPORE (Feb 14): UOB Kay Hian and Phillip Capital are maintaining their “buy” calls on Health Management International (HMI), both with target prices of 83 cents, after the group’s 1H results for FY2018 came in line with expectations.  

SINGAPORE (Jan 8): CIMB is maintaining its “add” call on Raffles Medical Group (RMG) with a target price of $1.24.

(Nov 30): After a 91% surge in its share price since 2016, Health Management International has gained an important new supporter – a unit of Singapore’s state investment firm.